243 related articles for article (PubMed ID: 32261055)
1. Polyelectrolyte multilayer functionalized mesoporous silica nanoparticles for pH-responsive drug delivery: layer thickness-dependent release profiles and biocompatibility.
Feng W; Zhou X; He C; Qiu K; Nie W; Chen L; Wang H; Mo X; Zhang Y
J Mater Chem B; 2013 Nov; 1(43):5886-5898. PubMed ID: 32261055
[TBL] [Abstract][Full Text] [Related]
2. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.
Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z
ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous Silica Nanoparticles Coated by Layer-by-Layer Self-assembly Using Cucurbit[7]uril for in Vitro and in Vivo Anticancer Drug Release.
Li QL; Sun Y; Sun YL; Wen J; Zhou Y; Bing QM; Isaacs LD; Jin Y; Gao H; Yang YW
Chem Mater; 2014 Nov; 26(22):6418-6431. PubMed ID: 25620848
[TBL] [Abstract][Full Text] [Related]
4. Fine tuning of the pH-sensitivity of laponite-doxorubicin nanohybrids by polyelectrolyte multilayer coating.
Xiao S; Castro R; Maciel D; Gonçalves M; Shi X; Rodrigues J; Tomás H
Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():348-356. PubMed ID: 26706540
[TBL] [Abstract][Full Text] [Related]
5. A carboxymethyl lentinan layer by layer self-assembly system as a promising drug chemotherapeutic platform.
Cai D; Shi L; Long R; Ren G; Wang S; Liu Y
Carbohydr Polym; 2021 Jun; 261():117847. PubMed ID: 33766343
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-loaded electrospun poly(l-lactic acid)/mesoporous silica nanoparticles composite nanofibers for potential postsurgical cancer treatment.
Qiu K; He C; Feng W; Wang W; Zhou X; Yin Z; Chen L; Wang H; Mo X
J Mater Chem B; 2013 Sep; 1(36):4601-4611. PubMed ID: 32261203
[TBL] [Abstract][Full Text] [Related]
7. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
8. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
9. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
10. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity.
Li J; Du X; Zheng N; Xu L; Xu J; Li S
Colloids Surf B Biointerfaces; 2016 May; 141():374-381. PubMed ID: 26878288
[TBL] [Abstract][Full Text] [Related]
11. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
[TBL] [Abstract][Full Text] [Related]
12. Mannosylated poly(acrylic acid)-coated mesoporous silica nanoparticles for anticancer therapy.
Lee H; Choi M; Kim HE; Jin M; Jeon WJ; Jung M; Yoo H; Won JH; Na YG; Lee JY; Seong H; Lee HK; Cho CW
J Control Release; 2022 Sep; 349():241-253. PubMed ID: 35798094
[TBL] [Abstract][Full Text] [Related]
13. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
[TBL] [Abstract][Full Text] [Related]
15. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
[TBL] [Abstract][Full Text] [Related]
16. Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy.
Kuang Y; Chen H; Chen Z; Wan L; Liu J; Xu Z; Chen X; Jiang B; Li C
Colloids Surf B Biointerfaces; 2019 Sep; 181():461-469. PubMed ID: 31176118
[TBL] [Abstract][Full Text] [Related]
17. Controlling antibiotic release from mesoporous silica nano drug carriers via self-assembled polyelectrolyte coating.
Tamanna T; Bulitta JB; Yu A
J Mater Sci Mater Med; 2015 Feb; 26(2):117. PubMed ID: 25665846
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
[TBL] [Abstract][Full Text] [Related]
19. Zwitterionic mesoporous nanoparticles with a bioresponsive gatekeeper for cancer therapy.
Khatoon S; Han HS; Lee M; Lee H; Jung DW; Thambi T; Ikram M; Kang YM; Yi GR; Park JH
Acta Biomater; 2016 Aug; 40():282-292. PubMed ID: 27063494
[TBL] [Abstract][Full Text] [Related]
20. Charge-Reversal APTES-Modified Mesoporous Silica Nanoparticles with High Drug Loading and Release Controllability.
Wang Y; Sun Y; Wang J; Yang Y; Li Y; Yuan Y; Liu C
ACS Appl Mater Interfaces; 2016 Jul; 8(27):17166-75. PubMed ID: 27314423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
